98 results
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:42am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:41am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
S-8 POS
PNT
POINT Biopharma Global Inc.
27 Dec 23
Registration of securities for employees (post-effective amendment)
9:39am
code, and telephone number, including area code of registrant’s principal executive offices)
POINT Biopharma Global Inc. 2021 Equity Incentive Plan … (the “2021 Plan”)
POINT Biopharma Inc. 2020 Equity Incentive Plan (the “2020 Plan”)
(Full Titles of the Plans)
Philip L. Johnson
President
Point
8-K
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
with the consummation of the Merger and effective as of the Effective Time, the Company terminated the POINT Biopharma Global Inc. 2020 Equity Incentive … Plan and the POINT Biopharma Global Inc. 2021 Equity Incentive Plan.
Item 2.01 Completion of Acquisition or Disposition of Assets.
The disclosures
SC 14D9
1lmxwhfm2m5jn8wth5
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
nl7jfnov
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.2
4acb0o17
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-2.1
81cznp7ejuu6z
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
kbqcvns8fqf7zvw799j7
3 Oct 23
Tender and Support Agreement
7:35am
S-8
166d ji1i6n4i2pao
14 Aug 23
Registration of securities for employees
10:22am
S-8
EX-5.1
bemx05llov txusj5c2g
14 Aug 23
Registration of securities for employees
10:22am
S-8
jdtsb
14 Aug 23
Registration of securities for employees
10:22am
ARS
zu3sdpq2z0c86pno2nc
1 May 23
Annual report to shareholders
1:52pm
8-K
EX-1.1
9k2kxftaforx 22na6
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm